The application of TGN-020, an AQP4 inhibitor, evoked the aggravation of reactive astrogliosis, glymphatic drainage restriction, and the loss of nigral DA-ergic neurons in an MPTP-induced PD model. The gene discussed is AQP4; the disease is Parkinson disease.